KLF10 Gene Expression is Associated with High Fetal Hemoglobin Levels and with Response to Hydroxyurea Treatment in β-Hemoglobinopathy Patients

• Weatherall DJ . Towards molecular medicine; reminiscences of the haemoglobin field, 1960–2000. Br. J. Haematol.115(4) , 729–738 (2001).
   PubMed Web of Science ®Google Scholar
• Patrinos G , AntonarakisS. Human Hemoglobin (4th Edition). Springer, Heidelberg, Germany (2010).
   Google Scholar
• Perrine SP , MillerBA, GreeneMF et al. Butyric acid analogues augment γ globin gene expression in neonatal erythroid progenitors. Biochem. Biophys. Res. Commun. 148(2) , 694–700 (1987).
   PubMed Web of Science ®Google Scholar
• Perrine SP , WarginWA, BoosalisMS et al. Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a Phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. J. Clin. Pharmacol. 51(8) , 1186–1194 (2011).
   PubMed Web of Science ®Google Scholar
• Constantoulakis P , KnitterG, StamatoyannopoulosG. On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5azaC and AraC. Blood74(6) , 1963–1971 (1989).
   PubMed Web of Science ®Google Scholar
• DeSimone J , HellerP, HallL, ZwiersD. 5azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc. Natl Acad. Sci. USA79(14) , 4428–4431 (1982).
   PubMed Web of Science ®Google Scholar
• Dover GJ , CharacheSH, BoyerSH, TalbotCC, SmithKD. 5azacytidine increases fetal hemoglobin production in a patient with sickle cell disease. Prog. Clin. Biol. Res.134 , 475–488 (1983).
   PubMedGoogle Scholar
• Mabaera R , GreeneMR, RichardsonCA, ConineSJ, KozulCD, LowreyCH. Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine‘s ability to induce human fetal hemoglobin. Blood111(1) , 411–420 (2008).
   PubMed Web of Science ®Google Scholar
• Ley TJ , AnagnouNP, NoguchiCT et al. DNA methylation and globin gene expression in patients treated with 5-azacytidine. Prog. Clin. Biol. Res. 134 , 457–474 (1983).
   PubMedGoogle Scholar
• Veith R , GalanelloR, PapayannopoulouT, StamatoyannopoulosG. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N. Engl. J. Med.313(25) , 1571–1575 (1985).
   PubMed Web of Science ®Google Scholar
• Moi P , KanYW. Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc. Natl Acad. Sci. USA87(22) , 9000–9004 (1990).
   PubMed Web of Science ®Google Scholar
• Yang YM , PaceB, KitchensD, BallasSK, ShahA, BaligaBS. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction. Am. J. Hematol.56(4) , 252–258 (1997).
   PubMed Web of Science ®Google Scholar
• Steinberg MH , LuZH, BartonFB, TerrinML, CharacheS, DoverGJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter study of hydroxyurea. Blood89(3) , 1078–1088 (1997).
   PubMed Web of Science ®Google Scholar
• Patrinos GP , GrosveldFG. Pharmacogenomics and therapeutics of hemoglobinopathies. Hemoglobin32(1–2) , 229–236 (2008).
   PubMed Web of Science ®Google Scholar
• Wilber A , NienhuisAW, PersonsDA. Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood117(15) , 3945–3953 (2011).
   PubMed Web of Science ®Google Scholar
• Alebouyeh M , MoussaviF, Haddad-DeylamiH, VossoughP. Hydroxyurea in the treatment of major βthalassemia and importance of genetic screening. Ann. Hematol.83(7) , 430–433 (2004).
   PubMed Web of Science ®Google Scholar
• Dixit A , ChatterjeeTC, MishraP et al. Hydroxyurea in thalassemia intermedia – a promising therapy. Ann. Hematol. 84(7) , 441–446 (2005).
   PubMed Web of Science ®Google Scholar
• Yavarian M , KarimiM, BakkerE, HarteveldCL, GiordanoPC. Response to hydroxyurea treatment in Iranian transfusion-dependent βthalassemia patients. Haematologica89(10) , 1172–1178 (2004).
   PubMed Web of Science ®Google Scholar
• Ma Q , WyszynskiDF, FarrellJJ et al. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J. 7(6) , 386–394 (2007).
   PubMed Web of Science ®Google Scholar
• Borg J , PapadopoulosP, GeorgitsiM et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat. Genet. 42(9) , 801–805 (2010).
   PubMed Web of Science ®Google Scholar
• Voskaridou E , ChristoulasD, BilalisA et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 115(12) , 2354–2363 (2010).
   PubMed Web of Science ®Google Scholar
• Giannopoulou E , BartsakouliaM, TafraliC et al. A single nucleotide polymorphism in the HBBP1 gene in the human β-globin locus is associated with a mild βthalassemia disease phenotype. Hemoglobin doi:10.3109/03630269.2012.717515 (2012) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Papachatzopoulou A , KourakliA, MakropoulouP et al. Genotypic heterogeneity and correlation to intergenic haplotype within high HbF βthalassemia intermedia. Eur. J. Haematol. 76(4) , 322–330 (2006).
   PubMed Web of Science ®Google Scholar
• Papachatzopoulou A , KaimakisP, PourfarzadF et al. Increased γ-globin gene expression in βthalassemia intermedia patients correlates with a mutation in 3´HS1. Am. J. Hematol. 82(11) , 1005–1009 (2007).
   PubMed Web of Science ®Google Scholar
• Leberbauer C , BoulméF, UnfriedG, HuberJ, BeugH, MüllnerEW. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood105(1) , 85–94 (2005).
   PubMed Web of Science ®Google Scholar
• de Hoon MJ , ImotoS, NolanJ, MiyanoS. Open source clustering software. Bioinformatics20(9) , 1453–1454 (2004).
   PubMed Web of Science ®Google Scholar
• Saldanha AJ . Java Treeview – extensible visualization of microarray data. Bioinformatics20(17) , 3246–3248 (2004).
   PubMed Web of Science ®Google Scholar
• Papachatzopoulou A , KourakliA, StavrouEF et al. Region-specific genetic heterogeneity of HBB mutation distribution in south-western Greece. Hemoglobin 34(4) , 333–342 (2010).
   PubMed Web of Science ®Google Scholar
• Thein SL . Genetic modifiers of sickle cell disease. Hemoglobin35(5–6) , 589–606 (2011).
   PubMed Web of Science ®Google Scholar
• Dingli D , TefferiA. Hydroxyurea: the drug of choice for polycythemia vera and essential thrombocythemia. Curr. Hematol. Malig. Rep.1(2) , 69–74 (2006).
   PubMedGoogle Scholar
• Platt OS . Hydroxyurea for the treatment of sickle cell anemia. N. Engl. J. Med.358(13) , 1362–1369 (2008).
   PubMed Web of Science ®Google Scholar
• Ware RE , DespotovicJM, MortierNA et al. Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood 118(18) , 4985–4991 (2011).
   PubMed Web of Science ®Google Scholar
• Schechter AN . Hemoglobin research and the origins of molecular medicine. Blood112(10) , 3927–3938 (2008).
   PubMed Web of Science ®Google Scholar
• Gallienne AE , DréauHM, SchuhA, OldJM, HendersonS. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica97(3) , 340–343 (2012).
   PubMed Web of Science ®Google Scholar
• Hu JH , NavasP, CaoH, StamatoyannopoulosG, SongCZ. Systematic RNAi studies on the role of Sp/KLF factors in globin gene expression and erythroid differentiation. J. Mol. Biol.366(4) , 1064–1073 (2007).
   PubMed Web of Science ®Google Scholar
• Siatecka M , BiekerJJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood118(8) , 2044–2054 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang JS , MoncrieffeMC, KaczynskiJ, EllenriederV, PrendergastFG, UrrutiaR. A conserved α-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol. Cell. Biol.21(15) , 5041–5049 (2001).
   PubMed Web of Science ®Google Scholar
• Alhashem YN , VinjamurDS, BasuM, KlingmüllerU, GaenslerKM, LloydJA. Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal β-globin genes through direct promoter binding. J. Biol. Chem.286(28) , 24819–24827 (2011).
   PubMed Web of Science ®Google Scholar
• Kalra IS , Alam mM, Choudhary PK, Pace BS. Krüppel-like factor 4 activates HBG gene expression in primary erythroid cells. Br. J. Haematol.154(2) , 248–259 (2011).
   PubMed Web of Science ®Google Scholar
• Uda M , GalanelloR, SannaS et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of βthalassemia. Proc. Natl Acad. Sci. USA 105(5) , 1620–1625 (2008).
   PubMed Web of Science ®Google Scholar
• Close J , GameL, ClarkB, BergouniouxJ, GerovassiliA, TheinSL. Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genomics5(1) , 33 (2004).
   PubMed Web of Science ®Google Scholar
• Squassina A , ManchiaM, BorgJ et al. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder. Pharmacogenomics 12(11) , 1559–1569 (2011).
   PubMed Web of Science ®Google Scholar

▪ Websites

• AltAnalyze software. www.altanalyze.org
   Google Scholar
• The HapMap Project. www.hapmap.org
   Google Scholar
• The National Institute of Environmental Health Sciences website. http://snpinfo.niehs.nih.gov/snpinfo/snptag.htm
   Google Scholar